ERBB2 and neoplasm: These nanomicelles demonstrated prolonged blood circulation (fluorescence~0.86 × 104 a.u. at 8 h) compared to monomeric counterparts (~0.4 × 104 a.u.), alongside reduced renal clearance, enhanced Her2-positive SKOV-3 tumor accumulation (up to 8 h), and near-complete tumor eradication in HER2-positive ovary (SKOV-3) and breast (BT474) models [42].